Client News & Interviews

Client articles, Beyond the Mic, interview summaries

Client News & Interviews

January 31, 2026 • Views: 8

HPQ Silicon’s Commercially Validated Fumed Silica Process Carries Potential for Global Disruption

Client News & Interviews

November 13, 2025 • Views: 10

HPQ Silicon Global Disruption Of Fumed Silica Is Analogous To What Desktop Computers Did To Super Computers

Client News & Interviews

November 11, 2025 • Views: 3

Quantum BioPharma Cuts Liabilities in Half, Boosts Equity 275%, and Strengthens Path to Phase 2 MS Trial

Client News & Interviews

October 29, 2025 • Views: 10

The Critical Role of the Myelin Sheath – And How Quantum BioPharma Is Advancing the Next Frontier in MS Neuroprotection

Client News & Interviews

October 21, 2025 • Views: 3

BEYOND THE MIC: PyroGenesis CEO Commits Up To $4 Million in Fresh Financing – Here’s Why That Matters

Client News & Interviews

October 16, 2025 • Views: 11

This Small Cap Company’s CEO Is Investing Another $4,000,000 of His Own Money

Client News & Interviews

September 8, 2025 • Views: 5

HPQ Silicon Hits Pilot-Scale Milestone Akin To Netflix 2000 For Fumed Silica Industry

Client News & Interviews

August 18, 2025 • Views: 2

Quantum BioPharma’s Year of Execution: Clinical Momentum, Platform Progress, and a Stronger Balance Sheet

Client News & Interviews

July 9, 2025 • Views: 1

PyroGenesis Posts $15.7M Revenue in 2024 — Plasma Tech Approved by Boeing & Used by the U.S. Navy

Client News & Interviews

July 3, 2025 • Views: 4

Lucid-MS: A New Approach in Quantum BioPharma’s Mission to Repair MS-Related Nerve Damage

↑